In the quest for answers, promising research has surfaced, hinting at a potential ally against Long COVID. Delve into the latest findings on Metformin's potential to reduce the risk of this persistent condition
Read More
A major breakthrough in heart failure treatment occurs as the FDA granted its approval for sotagliflozin (Inpefa), marking a significant milestone in cardiac care, providing renewed hope for patients and healthcare providers alike
Read More
A groundbreaking study from QIMR Berghofer Medical Research Institute has unveiled a promising finding - regular use of low dosages of aspirin may significantly improve ovarian cancer survival. This remarkable discovery offers newfound hope in the battle against ovarian cancer, shining a light on the potential benefits of this widely accessible medication in enhancing patient outcome
Read More
Exploring innovative tactics, Brigham and Women’s Hospital researchers trialed a Trojan horse strategy: harnessing cancer cells to combat the disease from within.
Read More
The pivotal outcomes of the RIVER Trial, which stands for Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation, have unveiled that rivaroxaban stands on par with warfarin in terms of effectiveness and impact.
Read More
A recent study explored the impact of canagliflozin on individuals dealing with both type 2 diabetes and the risks associated with heart disease.
Read More